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1  Introduction 
Ischemic heart disease is caused by atherosclerotic and/or 
thrombotic obstruction of coronary arteries. Clinical spec-
trum of ischemic heart disease expands from asymptomatic 
atherosclerosis of coronary arteries to acute coronary syn-
dromes (ACS) including unstable angina, acute myocardial 
infarction (non-ST elevation myocardial infarction and ST 
elevation myocardial infarction). Stable ischemic heart dis-
ease (SIHD) refers to patients with known or suspected 
SIHD who have no recent or acute changes in their symp-
tomatic status, suggesting no active thrombotic process is 
underway. These patients include those with (1) recent-onset 
or stable angina or ischemic equivalent symptoms, such as 
dyspnea or arm pain with exertion; (2) post-ACS stabilized 
after revascularization or medical therapy; and (3) asymp-
tomatic SIHD diagnosed by abnormal stress tests or imag-
ing studies. This review summarizes clinical features and 
management of SIHD in the older adult. ACS in older adults 
is not considered in this review. 
Age is a strong independent risk factor for the develop-
ment of atherosclerotic arterial disease. In the coming dec-
ades, tremendous increase of the prevalence of SIHD in the 
older adults is projected for the following reasons: (1) The 
world’s population is aging, with those aged 80 and older 
expanding most rapidly. (2) The elderly population makes 
up the majority of new angina pectoris patients. In the USA, 
the annual rates per 1000 population of new episodes of 
angina pectoris of nonblack men were reported to be 28.3 
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for those 65 to 74 years of age, 36.3 for 75 to 84 years of 
age and 33.0 for  85 years of age; and 14.1, 20.0 and 22.0 
for nonblack women in the same age groups; 22.4, 33.8 and 
39.5 for black women; 15.3, 23.6 and 35.9 for black women, 
respectively.[1] (3) The acute myocardial infarction (AMI) 
survival rate has improved dramatically under current ACS 
care, so large numbers of AMI patients become SIHD pa-
tients. (4) The increased use of non-invasive (coronary ar-
tery calcium score, coronary CT angiography, etc) and in-
vasive diagnostic modalities adds significantly to the num-
ber diagnosed with SIHD. SIHD in the older adult presents 
unique challenges to the healthcare community with pre-
dictable increasing burden but less clinical evidence to 
guide practice.  
In the older adults, SIHD has equal prevalence in men 
and women. Obstructive coronary artery disease (CAD) is 
often more diffuse and severe anatomically. These patients 
have higher prevalence of left main stenosis, multi-vessel 
disease and impaired left ventricular function than in 
younger patients. In this population, other pathophysiologi-
cal mechanisms may also cause myocardial ischemia and 
contribute to SIHD clinical presentation. These include mi-
crovascular dysfunction, endothelial dysfunction, vascular 
spasm or micro-embolism, left ventricular hypertrophy asso-
ciated microvascular insufficiency or other factors contribut-
ing to supply-demand imbalance.[2] Microvascular and en-
dothelial dysfunction are common in the older adult popula-
tion. Therefore, SIHD in the older adult requires a compre-
hensive approach, not only diagnosing and treating obstruc-
tive CAD, but also managing other potential etiologies.  
2  Clinical presentations and general evaluation 
A thorough history and physical examination is strongly 
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indicated for the evaluation of patients suspected of having 
SIHD. It provides critical information regarding typical ver-
sus atypical angina, cardiac versus non-cardiac symptoms, 
high risk vs. non-high risk features, as well as contributing 
non-cardiac etiologies. However, obtaining information 
accurately in older adults may be challenged by declining 
activity level, presence of comorbid conditions, cognitive 
impairment and atypical symptoms. Only a minority of 
older adults with ischemic heart disease complain of typical 
angina. Ischemia presentations are often characterized by 
lack of energy, exertional fatigue and dyspnea, epigastric or 
back discomfort. The origins of many of these symptoms 
are difficult to differentiate from chronic anemia, arthritis, 
gastric dysfunction, chronic lung disease, and overall physi-
cal inactivity. Post-prandial or emotional stress triggers may 
be common. Careful physical examination often leads to 
important clues of significant rhythms abnormalities (e.g., 
atrial fibrillation, bradycardia), valvular diseases, and pe-
ripheral arterial disease (e.g., carotid bruits, abdominal aorta 
aneurysm bruit and diminished pedal pulse).  
The prevalence of resting electrocardiographic (ECG) 
abnormalities is significantly higher in older asymptomatic 
women and men, such as the prevalence of large or inter-
mediate Q-waves, left axis deviation, T-wave inversions, 
left ventricular hypertrophy, bundle branch block and atrial 
fibrillation/flutter.[3] Many of these abnormalities confound 
the use of ECG in risk stratification and guide modality for 
non-invasive ischemia workup. Transthoracic echocardi-
ography is informative in the diagnosis and management of 
SIHD in the older adults, providing information on left 
ventricular function, segmental ventricular contractility, left 
ventricular hypertrophy, diastolic function, valvular disease, 
and aortic root condition.  
In contrast to an older adult with an acute presentation of 
coronary artery disease, an older adult who is asymptomatic 
or has stable symptoms benefits from CAD risk modifica-
tion and guideline directed preventive therapy. Additional 
ischemic workup may be warranted if symptoms are not 
managed with initial attempts at medical therapy. Figure 1. 
is the flow chart of assessment and management of SIHD in 
the elderly. 
3  Risk assessment and ischemia workup  
Clinical risk assessment is an important part of the SIHD 
workup in older adults. Prolonging survival with optimal 
quality of life is the main goal, and is informed by the pa-
tient’s underlying risk of adverse outcome and symptom 
status. Risk assessment incorporates socio-demographics, 
symptoms and signs, risk factors, comorbid conditions, 
laboratory data, ECG and other non-invasive or invasive 
ischemic workup results. Existing models used to assess the 
risk are derived from populations aged  70 years, so their  
specificity and sensitivity in the older adult are less certain. 
The selection of ischemic testing modalities should be based 
on an estimation of the pre-test probability of ischemic heart 
disease or obstructive CAD.[4] When pre-test probability of 
ischemic heart disease is low (< 20%), further workup is not 
recommended due to a concern of false positive rate ex-
ceeding the true positive rate. When the pre-test probability 
is high (> 80%), negative non-invasive test results may not 
exclude obstructive CAD, so an invasive approach may 
provide a more definitive answer. Patients with intermediate 
pre-test likelihood benefit most from stress testing.   
3.1  Exercise treadmill test 
Whereas exercise treadmill testing (ETT) is often used in 
the assessment of CAD, the diagnostic and prognostic sen-
sitivity and specificity of ETT is often questioned in older 
adults.[5] Lower exercise capacity associated with aging (i.e., 
effects of reduced peak heart rate, reduced muscle mass, as 
well as deconditioning) may limit exercise workload such that 
it is insufficient to provoke ischemic ECG changes or symp-
toms. Comorbidities associated with aging also often addition-
ally impede exercise, and baseline ECG abnormalities often 
diminish specificity of any exercise-induced ECG changes.  
 
Figure 1.  Flow chart of assessment and management of SIHD 
in the elderly. The corner stone of caring for SIHD is risk assess-
ment and optimizing GDMT. SIHD older adult have high risk of 
ischemic events and refactor symptoms despite optimized GDMT 
may be recommended by invasive coronary angiography and re-
vascularization. FFR: fractional flow reserve; GDMT: guideline di-
rected medical therapy; OCT: optical coherence tomography; MPI: 
myocardial perfusion imaging; SIHD: stable ischemia heart disease; 
IVUS: intravascular ultrasound. 
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While ETT is less useful to diagnose ischemia in older 
adults, it may still provide insights for clinical management.  
Symptoms, chronotropic responses, arrhythmias, hemody-
namics, exercise capacity, cardiorespiratory fitness, and 
other parameters can often by ascertained by exercise test-
ing. Furthermore, ETT can be coupled with cardiopulmon-
ary assessments and imaging assessments (e.g., myocardial 
perfusion imaging or echocardiography) to increase sensi-
tivity and specificity to detect ischemia, and to also ascer-
tain additional insights regarding pulmonary hypertension, 
valvular heart disease, and other pertinent aspects of disease 
and management.[6]  
3.2  Imaging modalities 
Both SPECT myocardial perfusion imaging (MPI) and 
echocardiology can be coupled with ETT to improve ische-
mic specificity and sensitivity.[7,8] The diagnostic/prognostic 
utilities of both modalities are similar to one other, and often 
depends on particular expertise and/or equipment that is 
available at different hospital centers.  
For older patients who are unable to exercise, pharma-
cological stress can be coupled with MPI or echocardiogra-
phy (i.e., pharmacological stress tests) to still enable diag-
nostic and risk stratification of SIHD in the older adult.[9] 
For MPI, vasodilating agents are usually the preferred phar-
macological stress option as they facilitate sensitive ische-
mic assessments that are generally well tolerated. For both 
MPI and echocardiographic pharmacologic studies, dobu-
tamine can also be used to provoke stress. Since dobutamine 
is relatively more likely to provoke arrhythmias and hemo-
dynamic lability than vasodilating agents, it is used rela-
tively less frequently for SPECT imaging, but it remains the 
primary pharmacological stimulus for pharmacologic echo-
cardiographic stress tests.   
3.3  Coronary calcium score and coronary CT angio-
graphy 
Older adults have high prevalence of coronary calcifica-
tion. For asymptomatic individuals 70 years of age or older, 
electron beam tomography (EBT) derived coronary artery 
calcium (CAC) score was found to improve prediction of 
coronary events based on cardiovascular risk factors in a 
population-based study, in particular, elderly persons with 
no or very low CAC have a lower mortality rate.[10] How-
ever, the value of CAC score in symptomatic elderly pa-
tients with suspected SIHD is limited. Coronary CT an-
giography (CCTA) is another commonly used imaging mo-
dality in detecting obstructive CAD and is found beneficial 
in younger adults. However, due to high prevalence of sig-
nificant coronary calcification, and inability to perform sat-
isfactory breath-hold for the scan, CCTA may be less accu-
rate and less feasible for some older patients.[11]  
3.4  Invasive coronary angiography 
Coronary angiography remains the “gold standard” for 
definitive evaluation of epicardial CAD. It provides infor-
mation for assessment of risk of death and future cardio-
vascular events. It is a prerequisite for ascertaining the fea-
sibility and selection of revascularization approaches if in-
dicated. In general, coronary angiography is recommended 
for patients whose clinical characteristics and/or results 
noninvasive testing indicate a high likelihood of severe IHD 
at high risk of coronary events or death. Coronary an-
giography is also recommended for patients with moderate 
clinical risk profile who have decreased left ventricular con-
tractile function, inconclusive prognostic information after 
non-invasive testing, or unsatisfactory quality of life thought 
to be due to IHD.[12] Coronary angiography is generally safe 
in the older adults. However, increased risks of bleeding, 
stroke, contrast-induced kidney injury and increased preva-
lence of peripheral arterial disease and tortuosity, chronic 
kidney disease, and decreased tolerance of sedative and 
narcotics, are factors requiring attention. Despite some risks, 
older adults may benefit from coronary angiography due to 
higher prevalence of multi-vessel and left main CAD, atyp-
ical presentations and inconclusive non-invasive testing. 
4  Treatment 
4.1  Treatment goals 
The goals for SIHD treatment include maximizing sur-
vival, minimizing risk of cardiovascular events and achiev-
ing nearly complete elimination of symptoms with return to 
normal activities. Older adults with declined baseline activ-
ity level, multiple serious coexisting conditions, may be 
satisfied with a reduction in symptoms that permits con-
tinuation of some limited activities of daily living. Therefore, 
individualized discussion about goals of treatments, risk and 
benefit of therapeutic approaches, especially revasculariza-
tion of obstructive CAD by either percutaneous coronary 
intervention (PCI) and coronary artery bypass grafting 
(CABG) surgery, is important. Patients’ preferences can 
vary as a function of age. Improvement of quality of life, 
eliminating symptoms and maintenance of independency in 
daily life become more important than prolonging length of 
life in the decision-making of the older adults.[13] 
4.2  Guideline-directed medical therapy and risk factor 
modification 
More than 30% SIHD patients are aged 75 years and 
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older, and these patients have higher mortality. Guideline- 
directed medical therapy (GDMT) is as effective as com-
pared to younger groups, with favorable benefit and risk 
ratio.[14,15] GDMT should be the initial approach in treating 
most patients with SIHD, including older adults. A com-
prehensive GDMT for SIHD would include: (1) patient 
education and counseling to promote lifestyle changes, i.e., 
smoking cessation, maintaining healthy weight, engaging 
physical activity, adopting healthy diet, achieving psycho-
social well-being and increasing medication adherence and 
involvement of self-monitoring; (2) pharmacological ther-
apy to optimize risk factor modification, i.e., blood pressure, 
glucose and cholesterol control and treating other comorbid 
conditions; (3) medical therapy to prevent MI with anti- 
platelet therapy and other agents; and (4) medical therapy to 
relieve ischemic symptoms. All agents proven to be benefi-
cial to younger groups with SIHD may be used in the older 
adults, with cautions to be paid due to alteration of cardio-
vascular physiology and their response to each medication 
(Table 1). These approaches/agents decrease SIHD patient’s 
vulnerability, partially by its plaque stabilizing effects via 
reducing inflammation, lipid content, and thrombotic poten-
tial and improving endothelial dysfunction. Selection of 
agents for older adults might be also individualized accord-
ing to comorbidities, contra-indications, adverse effects, 
drug and costs, and personal preference. 
4.3  Revascularization therapy 
Older adults are known to have increased mortality and 
morbidity undergoing PCI and CABG revascularization 
comparing to younger patients. Revascularization and its 
approach should be carefully planned after considerations of 
coronary anatomy, technical feasibility, risks of complica-
tion, patient preferences, functional capacity, goal of care, 
quality-of-life, life-expectancy, and end-of-life issues, as 
well as alternative therapies. Nevertheless, SIHD patients 
with refractory symptoms despite GDMT, particularly if 
evidence of moderate or severe ischemia in non-invasive 
diagnostic tests, should be considered for invasive coronary 
angiographic and optimal revascularization. In the TIME 
study, faster symptom relief and improved exercise capacity 
were achieved by revascularization in comparison to 
GDMT alone in elderly SIHD patients (aged  75 years 
with mean 80 years).[16] Revascularization also reduces hos-
pitalization, non-fatal MI and improves survival in the eld-
erly population.  
The comparative effectiveness of PCI and CABG for 
SIHD are an ongoing topic of debate which continues to 
evolve as new approaches, stents and understanding of 
complete revascularization enter the discussion. Selection of 
approach should consider CAD lesion complexity (SYN-
TAX score as a surrogate), surgical risk (STS score, Euro-
Score), comorbid conditions, functional capacity, and pa-
tient’s preference. Limited data suggests comparable mor-
tality and symptom relief between CABG and PCI, but very 
few patients aged  75 years were included in these studies. 
CABG may result in a higher rate of complete revascu-
larization, lower recurrence of symptoms and better long 
term mortality. However, CABG requires longer recovery, 
higher risk of stroke and peri-procedural neurological com-
plications (60% post CABG elderly patients experience 
short term and 20% long term cognitive impairment), as 
well as higher costs for the index hospitalization and life-
time.[17,18] To many older adults, improving quality of life, 
eliminating adverse symptoms and maintaining independ-
ence in daily life becomes more important than prolonging 
the length of life in the decision-making process. It is un-
derstandable that a less invasive approach with PCI is pref-
erable among older adults. Advancement of PCI techniques 
(i.e., increased use of radial artery approach, more sophisti- 
Table 1.  Categories of pharmacotherapy for management of SIHD. 
GDMT agents Risk factor modification MI risk reduction Symptom relief Mortality reduction Cautions for older adults 
Aspirin No Yes Yes Yes Increased risk of bleeding 
BBs Yes Yes Yes Yes 
High prevalence of adrenergic dysfunction, 
bradycardia and hypotension 
CCBs Yes Yes Yes No High incidence of bradycardia and hypotension
ACEi/ARB Yes Yes No Yes 
Vulnerable kidney function, high prevalence of 
renal artery stenosis 
Statin Yes Yes No Yes High rate of intolerance and adverse effects 
Nitroglycerin No No Yes No Less hemodynamic reserve, hypotension 
Ranolazine No No Yes No Increased rate of non-specific adverse effects 
Nicorandil Yes Yes Yes No 
Comparable to isosorbide mononitrate, no 
special adverse effect reported 
ACEi: angiotensin-converting-enzyme inhibitor; ARB: angiotensin receptor blockers; BBs: beta-adrenergic blocking agents; CCBs: calcium channel blocking 
agents; MI: myocardial infarction; SIHD: stable ischemic heart disease. 
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cated devices and balloon/stent designs) and rigorous and 
standardized professional training and regulations, adjunc-
tive pharmacotherapy and post procedure dual antiplatelet 
therapy contribute to steadily declined procedural complica-
tions.[19] However, comparing with younger patients, PCI 
has higher rate of complications including bleeding, stroke, 
contrast-induced kidney injury and post-procedural MI in 
older adults.[20] Drug eluting stents reduce the rates of 
in-stent restenosis compared with bare metal stents but re-
quire longer duration of dual antiplatelet therapy associated 
increased risk of bleeding.  
5  Follow-up care and cardiac rehabilitation 
Considering that older adults with SIHD often have mul-
tiple comorbidities, it is essential to have appropriate clini-
cal follow-up to ensure regular communication. Secondary 
prevention in the elderly has been addressed extensively in 
previous review.[20] Comprehensive, exercise-centered car-
diac rehabilitation is effective in reducing mortality, de-
creasing hospitalization and improving quality-of-life in 
older SIHD patients. Exercise training improves exercise 
tolerance and functional capacity, and education and coun-
seling reduces the risk of further cardiac events by optimiz-
ing pharmacological therapy (e.g., monitoring and encour-
aging concordance with medication). Other important out-
comes of patient education include promotion of a healthy 
lifestyle (e.g., smoking cessation, dietary advice, increasing 
physical activity) and identifying and counseling of post 
cardiac event psychological stresses.  
6  Future opportunities and clinical pearls 
There are opportunities for research: (1) comparative ef-
fectiveness of GDMT alone and GDMT plus revasculariza-
tion in the older adult with SIHD; (2) comparative effec-
tiveness of multivessel PCI with new generation drug 
eluting stents or CABG for older adults with left main or 
complex multi-vessel CAD; and (3) optimizing risk assess-
ment of SIHD in older adults with invasive (angiography) or 
non-invasive (CCTA and echo) testing.  
Clinical pearls include: (1) SIHD is common in older 
adults with equal prevalence in men and women. (2) Older 
adults with SIHD have more comorbidities and higher risk 
profiles. They have a high prevalence of multi-vessel CAD, 
left main disease and left ventricular dysfunction. (3) Exer-
cise stress test with and without pharmacological stress 
combined with myocardial perfusion imaging is often used 
for risk assessment. (4) Invasive coronary angiography is 
reserved for older adults with SIHD and high likelihood of 
severe IHD in non-invasive testing, or moderate risk with 
depressed left ventricular function, or inconclusive non-in-
vasive testing and unsatisfactory symptom controls despite 
optimized GDMT. (5) GDMT is the first line therapy for 
older adult with SIHD. This modality includes lifestyle 
modification and pharmacotherapy with the goals of risk 
factor modification, reduction of MI risk, symptoms relief 
and prolonging of life. (6) Older adults with refractory 
symptoms affecting quality of life despite optimized GDMT 
should be referred for revascularization. (7) Clinic fol-
low-up and cardiac rehabilitation are integrative compo-
nents of care for SIHD in the older adults. 
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